Children's Hair Loss / Alopecia Areata

Phase

Condition

Healthy Children Studies

Hair Loss

Treatment

N/A

Clinical Study ID

TX313524

Ages 6-17
All Genders

Study Summary

Is your child or adolescent suffering from alopecia areata?

The BRAVE-AA-PEDS Study is testing how safe and effective a study drug is for children and adolescents with alopecia areata or AA.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Be at least 6 and less than 18 years old
Have severe AA for at least a year
Have a current AA episode that has lasted at least 6 months
Have AA that has not improved on its own
Have tried at least 1 AA treatment, and it failed
The study team will review additional qualifications your child or adolescent may need to join this study

Exclusion

Exclusion Criteria:

Study Design

Study Description

Participation in the BRAVE-AA-PEDS Study is completely voluntary, and you can end your child or adolescent's participation at any time.

Doctors with a specialty in dermatology and experience in treating children and adolescent patients are conducting this study. The study drug and study- related medical care will be provided at no cost. Travel reimbursement may be available.

Connect with a study center

ACRC Trials
Grapevine, Texas 76051
United States
Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.